Henry RR, Thakkar P, Tong C, Polidori D, Alba M. Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes. Diabetes Care. 2015 Dec;38(12):2258-65. \[[PubMed: 26486192](https://pubmed.ncbi.nlm.nih.gov/26486192)\] 22. Pfützner A, Klonoff D, Heinemann L, Ejskjaer N, Pickup J. Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology. Endocrine. 2017 Apr;56(1):212-216. \[[PubMed: 28303514](https://pubmed.ncbi.nlm.nih.gov/28303514)\] 23. Bonner C, Kerr-Conte J, Gmyr V, Queniat G, Moerman E, Thévenet J, Beaucamps C, Delalleau N, Popescu I, Malaisse WJ, Sener A, Deprez B, Abderrahmani A, Staels B, Pattou F. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med. 2015 May;21(5):512-7. \[[PubMed: 25894829](https://pubmed.ncbi.nlm.nih.gov/25894829)\] 24. Ferrannini E, Muscelli E, Frascerra S, Baldi S, Mari A, Heise T, Broedl UC, Woerle HJ. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest. 2014 Feb;124(2):499-508. \[[PMC free article: PMC3904627](/pmc/articles/PMC3904627/)\] \[[PubMed: 24463454](https://pubmed.ncbi.nlm.nih.gov/24463454)\] 25. Crespo L, McConnell B, Wick JY. Euglycemic Diabetic Ketoacidosis: Hidden in Plain Sight. Consult Pharm. 2016;31(8):426-34. \[[PubMed: 27535077](https://pubmed.ncbi.nlm.nih.gov/27535077)\] 26. Umpierrez GE. Diabetes: SGLT2 inhibitors and diabetic ketoacidosis - a growing concern. Nat Rev Endocrinol. 2017 Aug;13(8):441-442. \[[PubMed: 28621337](https://pubmed.ncbi.nlm.nih.gov/28621337)\] 27. Bader N, Mirza L. Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin. Pak J Med Sci. 2016 May-Jun;32(3):786-8. \[[PMC free article: PMC4928443](/pmc/articles/PMC4928443/)\] \[[PubMed: 27375734](https://pubmed.ncbi.nlm.nih.gov/27375734)\] 28. Sinha N, Venkatram S, Diaz-Fuentes G. Starvation ketoacidosis: a cause of severe anion gap metabolic acidosis in pregnancy. Case Rep Crit Care. 2014;2014:906283. \[[PMC free article: PMC4055099](/pmc/articles/PMC4055099/)\] \[[PubMed: 24963418](https://pubmed.ncbi.nlm.nih.gov/24963418)\] 29. Lucero P, Chapela S. Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature. Case Rep Crit Care. 2018;2018:1747850. \[[PMC free article: PMC6188774](/pmc/articles/PMC6188774/)\] \[[PubMed: 30364093](https://pubmed.ncbi.nlm.nih.gov/30364093)\] 30. Dass B, Beck A, Holmes C, Morton G. Euglycemic DKA (euDKA) as a presentation of COVID-19. Clin Case Rep. 2021 Jan;9(1):395-398. \[[PMC free article: PMC7753533](/pmc/articles/PMC7753533/)\] \[[PubMed: 33362928](https://pubmed.ncbi.nlm.nih.gov/33362928)\] 31. Dhatariya K. Blood Ketones: Measurement, Interpretation, Limitations, and Utility in the Management of Diabetic Ketoacidosis. Rev Diabet Stud. 2016 Winter;13(4):217-225. \[[PMC free article: PMC5734222](/pmc/articles/PMC5734222/)\] \[[PubMed: 28278308](https://pubmed.ncbi.nlm.nih.gov/28278308)\] 32. Kang CY, Khamooshi P, Reyes Pinzon V. An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists. Cureus. 2022 Apr;14(4):e24016. \[[PMC free article: PMC9091341](/pmc/articles/PMC9091341/)\] \[[PubMed: 35573514](https://pubmed.ncbi.nlm.nih.gov/35573514)\] 33. Fernandez Felix DA, Madrigal Loria G, Sharma S, Sharma S, Arias Morales CE. A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured